SCHEMBL7041722

SCHEMBL7041722

COc1ccc(CNc2ccc(S(=O)(=O)Oc3ccc4[nH]c(NC(=O)C5CC5)nc4c3)cc2)cc1.O=C(Nc1nc2cc(OS(=O)(=O)c3ccc(Nc4ccc5[nH]cnc5c4)cc3)ccc2[nH]1)C1CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ULK1 O75385 1/20 0.39
QPCT Q16769 1/20 0.38
ENPP3 O14638 3/20 0.36
ENPP1 P22413 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
ENPP2 Q13822 2/20 0.36
KMT2A Q03164 2/20 0.36
GSK3B P49841 3/20 0.36
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
MET P08581 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
CDK9 P50750 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36
TUBB8 Q3ZCM7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5036479 0.91 ULK1 (0.45) ULK1ENPP3ENPP1NPC1RAB9A
SCHEMBL5036018 0.90 SMN1; SMN2 (0.43) ENPP3ENPP1NPC1RAB9AENPP2
SCHEMBL5037833 0.85 ENPP1 (0.51) ENPP3ENPP1NPC1RAB9AENPP2
SCHEMBL5033498 0.84 ENPP3 (0.44) ENPP3ENPP1ENPP2KMT2ASMN1; SMN2
SCHEMBL5036631 0.84 KMT2A (0.45) ENPP3ENPP1ENPP2KMT2ATUBB4A
SCHEMBL5036147 0.83 SMN1; SMN2 (0.42) ULK1ENPP3ENPP1NPC1RAB9A
SCHEMBL5043081 0.83 SMN1; SMN2 (0.48) ENPP3ENPP1NPC1RAB9AENPP2
SCHEMBL5040856 0.83 TP53 (0.42) ENPP3ENPP1NPC1RAB9AENPP2
SCHEMBL5040722 0.83 SMN1; SMN2 (0.42) ENPP3ENPP1NPC1RAB9AENPP2
SCHEMBL5036505 0.82 SMN1; SMN2 (0.43) ENPP3ENPP1NPC1RAB9AENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432417-A2 SUBSTITUTED BENZIMIDAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER Aventis Pharma S.A. (FR) 2004-06-30 EP disclosed
WO-2003028721-A2 SUBSTITUTED BENZIMIDAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER AVENTIS PHARMA S.A. (FR) 2003-04-10 WO disclosed